(Q40268937)

19 September 2017

Systemic corticosteroids for community-acquired pneumonia: reasons for use and lack of benefit on outcome (English)

1 reference

19 September 2017

Elena Prina

7

0 references

Catia Cillóniz

object named as

Catia Cillóniz

2

0 references

Eva Polverino

object named as

Eva Polverino

1

0 references

author name string

Povilas Dambrava

3

1 reference

19 September 2017

Albert Gabarrús

4

1 reference

19 September 2017

Miquel Ferrer

5

1 reference

19 September 2017

Carlos Agustí

6

1 reference

19 September 2017

Beatriz Montull

8

1 reference

19 September 2017

Rosario Menendez

9

1 reference

19 September 2017

Michael S Niederman

10

1 reference

19 September 2017

Antoni Torres

11

1 reference

19 September 2017

1 February 2013

1 reference

19 September 2017

1 reference

19 September 2017

18

1 reference

19 September 2017

263-271

1 reference

19 September 2017

2

1 reference

Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study

19 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12013

Effects of systemic steroids in patients with severe community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12013

Effect of corticosteroids on the clinical course of community-acquired pneumonia: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12013

Efficacy of corticosteroids in community-acquired pneumonia: a randomized double-blinded clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12013

The role of corticosteroids in severe community-acquired pneumonia: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12013

BTS guidelines for the management of community acquired pneumonia in adults: update 2009

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12013

A prediction rule to identify low-risk patients with community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12013

Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12013

Effects of glucocorticoids in ventilated piglets with severe pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12013

Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12013

Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12013

Macrophage activation in exacerbated COPD with and without community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12013

Observational study of inhaled corticosteroids on outcomes for COPD patients with pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12013

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12013

Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12013

Severe community-acquired pneumonia. Risk factors and follow-up epidemiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12013

Reaching stability in community-acquired pneumonia: the effects of the severity of disease, treatment, and the characteristics of patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12013

Appropriate antibiotic utilization in seniors prior to hospitalization for community-acquired pneumonia is associated with decreased in-hospital mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12013

Impact of systemic corticosteroids on the clinical course and outcomes of patients with severe community-acquired pneumonia: A cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12013

21 January 2018

Identifiers

DOI

10.1111/RESP.12013

1 reference

19 September 2017

1 reference